Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reduced 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-initiated oxidative DNA damage and neurodegeneration in prostaglandin H synthase-1 knockout mice.

ACS chemical neuroscience - 19 May 2010

Jeng Winnie, Wells Peter G

Abstract excerpt

The neurodegenerative potential of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and underlying mechanisms are under debate. Here, we show that MDMA is a substrate for CNS prostaglandin H synthase (PHS)-catalyzed bioactivation to a free radical intermediate that causes reactive oxygen species (ROS) formation and neurodegenerative oxidative DNA damage. In vitro PHS-1-catalyzed bioactivation of MDMA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 8-Hydroxy-2'-Deoxyguanosine
Share to Cyclooxygenase 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Deoxyguanosine

Share to Dopaminergic Neurons

Share to Free Radicals

Share to N-Methylaspartate

Share to Presynaptic Terminals

Share to Psychomotor Performance

Source

Open in PubMed Open full text

Identifiers

PMID: 22778832
DOI: 10.1021/cn900022w
PMCID: PMC3368639

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reduced 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-initiated oxidative DNA damage and neurodegeneration in prostaglandin H synthase-1 knockout mice.PMID 22778832Read ↗

Dihydroxy-Metabolites of Dihomo-gamma-linolenic Acid Drive Ferroptosis-Mediated NeurodegenerationSemantic proximity Read ↗

Epigenetic Effects Induced by Methamphetamine and Methamphetamine‐Dependent Oxidative StressSemantic proximity Read ↗

Oxoguanine Glycosylase 1 Protects Against Methamphetamine-Enhanced Fetal Brain Oxidative DNA Damage and Neurodevelopmental DeficitsSemantic proximity Read ↗

Differential Regulation of Neurotoxin in HIV Clades: Role of Cocaine and MethamphetamineSemantic proximity Read ↗

Blockade of PKCdelta proteolytic activation by loss of function mutants rescues mesencephalic dopaminergic neurons from methylcyclopentadienyl manganese tricarbonyl (MMT)-induced apoptotic cell death.Semantic proximity Read ↗

Pharmahuasca Reduces ROS Production and inflammatory Gene Expression in the Brain in a Model of PTSD: Exploration by RNA SequencingSemantic proximity Read ↗

Distinct gene expression signatures in the striata of wild-type and heterozygous c-fos knockout mice following methamphetamine administration: evidence from cDNA array analyses.Semantic proximity Read ↗

Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl.Semantic proximity Read ↗

Photomutagenicity of chlorpromazine and its N-demethylated metabolites assessed by NGS.Semantic proximity Read ↗

Developmental exposure to MDMA (ecstasy) in zebrafish embryos reproduces the neurotoxicity adverse outcome ‘lower motor activity’ described in humansSemantic proximity Read ↗

COX-2-deficient mice are less prone to MPTP-neurotoxicity than wild-type mice.Semantic proximity Read ↗

Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.